Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Nov 15 - Nov 20
doi: 10.1039/D0FO01444C 174 WanXMinYBludauHKeithASheikoSSJordanRet al
GLP-1 neuronal circuits in hypothalamic appetite regulation and food reward processing Metabolic surgery pharmacology : Studying whether pharmacological dual incretin agonism can replicate the hormonal changes and metabolic benefits of bariatric surgery Cardiovascular research : Elucidating mechanisms of cardiovascular risk reduction via combined GIP/GLP-1 receptor activation NASH/MAFLD research : Exploring effects on hepatic steatosis, inflammation, and fibrosis (SYNERGY-NASH trial ongoing) Peptide engineering : Studying multi-target receptor agonism as a design paradigm how to engineer selectivity ratios across receptor families Comparative pharmacology : Benchmarking dual (GIP/GLP-1) vs
Human pharmacokinetic data from the 1999 PK/PD study (PMID: 10496658) documented a plasma half-life of approximately 2 hours in humans
Besides, side effects could interfere with food preferences, leading to suboptimal intake of specific foods
